PRELIMINARY REMARKS FROM THE PRESS POINT OF THE PRESIDENT OF THE REPUBLIC AT THE END OF THE EXTRAORDINARY EUROPEAN COUNCIL.

France Emmanuel Macron · President of France

25 February 2021 · Extraordinary European Council

Context
Macron addressed press at an Extraordinary European Council on February 25, 2021, summarizing EU coordination efforts on COVID-19 vaccines and variants.
Main themes
COVID-19 vaccination coordination, European vaccine production autonomy, combating virus variants, vaccine orders and delivery acceleration, European HERA/BARDA initiative, vaccination certificates, export control mechanisms, cross-border movement, international solidarity and ACT-A, European unity
Duration
~11 min
40th percentile
Words
1,369
40th percentile
Sentences
51
33rd percentile
Readability
33
21st percentile
Grade
15.3
78th percentile
Syntax
3.26
78th percentile
Vocabulary
2.20
48th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 45%45%
  • Geopolitical 24%24%
  • Economic 12%12%
  • Institutional 10%10%
  • Ceremonial 10%10%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

51 sentences in 14 paragraphs

Hello everyone,

We have gathered for a European Council whose first part took place this afternoon and will continue tomorrow morning, which has allowed us in the hours that have passed to continue the coordination efforts we have engaged in the fight against the virus. Regarding the current situation, we have agreed on the urgency of combating the variants of the virus and have supported the Commission's launch of a kind of European BARDA, HERA, which will bring together laboratories, researchers, industry players, regulators, and will rely on European funding, so that we can meet the challenge of innovation, production, and delivery of health products in Europe. We also discussed the new orders from the European Commission to Pfizer and Moderna and called for the acceleration of ongoing deliveries, as well as negotiations for future vaccines, particularly concerning the laboratories Novavax and Valneva.

The European approach, as you know, I defend because it is the only way to organize an effective vaccination campaign in Europe, and it is bearing fruit. We have been able to rely on several types of vaccines with different technologies, so that all member states can deploy their vaccination strategy in parallel since the end of December. To go in a disorganized manner would have been pointless, as we see today, given that the issue of variants is being felt precisely everywhere in Europe.

Our objective is to secure the orders placed, to continue producing more in Europe, and we have seen this week the announcement of several laboratories that have agreed to convert production sites to produce existing and approved vaccines and prepare for future production. In this regard, we also had a discussion on strengthening production on European soil, by identifying the still available capacities of certain industrial players who could assist in the production of the vaccine and other health products, the continuation of second-generation vaccines that will arrive in the fall, as well as identifying our needs in terms of inputs with very clear mappings. I want to thank the Commission for the important work that has been done in recent weeks on this subject by President VON DER LEYEN and the task force led by Commissioner BRETON with a dedicated team.

The European Union is positioning itself to produce, as the European Commission has said, in a much more autonomous manner starting at the end of the year, and sustainably, as it is likely that we will have to live with this virus for the long term and therefore continue vaccination campaigns. We need to strengthen this European autonomy.

We also need to have transparent information on what companies based in Europe produce and export. This is the purpose of the export control and authorization mechanism that we have sought to continue. I have also drawn attention to the importance of having a comparable mechanism for all components for vaccines as well as treatments or diagnostics.

These variants, therefore, must lead us to the greatest vigilance and coordination, particularly with our neighbors. I have reminded you that control measures may be necessary at certain internal borders of the European Union, particularly to combat the spread of variants. But the general principle must remain that of preserving the movement of cross-border workers and transporters, simply to avoid fragmenting living areas and breaking supply chains. We can reconcile the coherence of our lives with the fight against the virus and the spread of variants.

This same unity and coordination are necessary regarding vaccination certificates. I can return to this in the questions if you wish; these certificates are to be distinguished from the mechanisms we are preparing in each of our countries. They will simply allow, once vaccination campaigns are completed in the European Union, to reorganize circulation between member states in a more fluid manner. I understand in this regard the hope for a return to normal life that the development of such a tool generates. But here too, we must find a balance. We must avoid each country developing its own system, and therefore work towards a common medical certification. And at the same time, while our populations have not yet all had access to the vaccine, which is administered on a voluntary basis, and for the moment with age criteria, such a document should not grant specific rights to vaccinated individuals. There are therefore important health, ethical, and legal questions that we must work on in the coming months.

Finally, and this is a point I have returned to at length, Europe must play its full part in international solidarity to effectively combat this global pandemic. A year ago, we launched the ACT-A initiative, solidarity for Africa, and it is clear that we need to build this solidarity towards our neighbors, whether in the Balkans or particularly in Africa. This solidarity is based on health aid for vaccines, treatments, diagnostics, support for primary health systems, the production of all this equipment, but also economic support, as we have already begun to do and as we will continue to do.

Regarding vaccines, I had the opportunity to advocate for the idea put forward by France at the G7 last week and to respond, in doing so, to the call that the World Health Organization, the International Organization of La Francophonie, the African Union, and the European Parliament have made to us today. Indeed, we will not sustainably defeat this virus unless we manage to develop a vaccination campaign across the planet, particularly among our African neighbors and friends. We know that there are 6.5 million healthcare workers on the African continent, which means mobilizing 13 million doses. These doses represent 0.43% of those ordered by the European Union, the United States, Canada, and Japan. It is a minimal effort but one that must be organized in the coming weeks and months. This is what we have agreed upon, without it disrupting in any way our domestic vaccination campaigns. This solidarity is extremely important and will be the condition for the credibility of the so-called COVAX mechanism.

We will resume our work tomorrow morning on two other important themes: that of European defense and that of our southern neighborhood. Regarding European defense, we reminded ourselves on February 5 with Chancellor MERKEL that we must continue to work on strengthening our collective analysis of threats and our capabilities. This is what the new strategic compass project initiated by the German presidency of the Council should contribute to, which should conclude under the French presidency in the first half of 2022.

Since 2017, we have made significant progress in this European defense. With permanent structured cooperation with certain states, the launch of the European Defense Fund, the European Peace Facility, and the launch of the European Intervention Initiative, we have structured something profoundly new that will also manifest through industrial cooperation and greater technological sovereignty. We are now opening a new chapter that should help us project ourselves towards 2030 to adapt our operations to current challenges and anticipate new forms of threats: cyber, maritime, spatial, aerial. And it is only by continuing down this path that Europe can take its rightful place in collective security and be a reliable and credible ally, particularly through the European pillar of NATO.

Finally, we will address the subject of our cooperation with our major partners in the southern neighborhood in this shared space that is the Mediterranean. The Commission recently proposed a new common agenda so that we can jointly invest up to 7 billion euros for the period 2021-2027. We must seize this new program to support the youth of these countries, investments in green technologies, and dialogue between our civil societies. That is why it is also important for heads of state and government to discuss these ambitious perspectives together with our neighbors to the south of the Mediterranean. And you know how much I value and believe in this format. The Summit of the Two Shores will aim to outline the French and European agenda in this area by deeply involving civil societies.

These are the few words I wanted to share with you this evening at the conclusion of this first part of the European Council and before answering your questions.